| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/09/2006 | WO2006014136A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | WO2006013393A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | WO2006013049A2 Benzyloxy derivatives as maob inhibitors |
| 02/09/2006 | WO2005118558A3 Pyrimidine compounds and use thereof |
| 02/09/2006 | WO2005086898A3 Inhibitors of histone deacetylase |
| 02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 02/09/2006 | US20060030709 PNA monomer and precursor |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 02/09/2006 | US20060030589 N-(8H-Indeno[1,2-d]thiazol-2-yl)-benzamide; antidiabetic agent; adenosine 2B receptor antagonists; antidiabetic agent; diabetic retinopathy, asthma and diarrhea; antidepressant, hypotensive agent, Parkinson's disease |
| 02/09/2006 | US20060030588 Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030567 Agriculture or horticulture; for controlling or preventing infestation of plants by phytopathogenic microorganisms, fungi |
| 02/09/2006 | US20060030559 Diazole derivatives |
| 02/09/2006 | US20060030558 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030554 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | CA2575936A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | CA2575018A1 Benzyloxy derivatives as maob inhibitors |
| 02/09/2006 | CA2574841A1 White light-emitting electroluminescent device |
| 02/09/2006 | CA2573124A1 Anti-inflammatory medicaments |
| 02/09/2006 | CA2573063A1 Compounds useful for inhibiting chk1 |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623981A1 Anti-leishmania agent |
| 02/08/2006 | EP1623977A1 Intermediate compound which is used for the preparation of pioglitazone |
| 02/08/2006 | EP1622900A1 Aztreonam beta-polymorph with very low residual solvent content |
| 02/08/2006 | EP1622899A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 02/08/2006 | EP1622898A1 Processes for making thiazolidinedione derivatives and compounds thereof |
| 02/08/2006 | EP1622897A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/08/2006 | EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/08/2006 | EP1622884A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1). |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP1622616A2 Inhibitors of akt activity |
| 02/08/2006 | EP1622615A2 Naphthyridine integrase inhibitors |
| 02/08/2006 | EP1622610A1 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1131292B1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 02/08/2006 | EP1109795B1 Thiazoline acid derivatives |
| 02/08/2006 | EP0812318B1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 02/08/2006 | CN1732172A Epothilone derivatives |
| 02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 02/08/2006 | CN1732164A Compositions useful as inhibitors of ROCK and other protein kinases |
| 02/08/2006 | CN1732159A 2-oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors |
| 02/08/2006 | CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 02/08/2006 | CN1731999A Benzothiazole derivatives |
| 02/08/2006 | CN1731994A Prophylactic and therapeutic agent for neuropathy |
| 02/08/2006 | CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 02/08/2006 | CN1240699C Remedies or preventives for diseases in association with chemokines |
| 02/08/2006 | CN1240691C Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/07/2006 | US6995185 Δ1-pyrrolines used as pesticides |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006011157A2 Methods for the preparation of aryl piperazinyl-heterocyclic compounds |
| 02/02/2006 | WO2006010964A1 New 4-benzylidene-piperidin derivatives |
| 02/02/2006 | WO2006010653A1 New polymorphous form of rosiglitazone maleate |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | WO2005072308A9 Cgrp receptor antagonists |
| 02/02/2006 | US20060025599 Benzyloxy derivatives |
| 02/02/2006 | US20060025591 New uracils having a herbicidal activity |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
| 02/02/2006 | US20060025453 inhibitor for treating a chemokine mediated disease; cancer, angiogenesis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, pain |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025422 Remedy for integration dysfunction syndrome |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025412 Enzyme inhibitors as bactericides for infections |
| 02/02/2006 | US20060025410 2,4-Pyrimidinediamine compounds and their uses |
| 02/02/2006 | US20060025406 Modulators of hepatocyte growth factor/c- Met activity |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/02/2006 | US20060024393 Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases |
| 02/02/2006 | DE102004033794A1 Kationische Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Cationic metal complexes as light-absorbing compounds in the information layer of optical media |
| 02/02/2006 | CA2574660A1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use |
| 02/02/2006 | CA2574148A1 4-benzylidene-piperidine derivatives |
| 02/02/2006 | CA2573920A1 Histamine-3 receptor antagonists |
| 02/02/2006 | CA2571324A1 Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621539A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620431A1 3-carbonylaminothiophenes and their use as fungicides |
| 02/01/2006 | EP1620420A2 Substituted carboxylic acids |
| 02/01/2006 | EP1620411A2 Inhibitors of akt activity |